| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D515-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 |
| filingDate |
2004-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bb6b224eb6121d3d38b351ea65cee1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_950e83778b8f9e4f1f5620d90f18108e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185c8f22b5755384d233d145d13ebd3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3802dec65ca681d8e781e4b7417a1e0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8ef8858c6a823537c967e2a547b8424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5440886f03980146e6d9920fccdbdcf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006d9163dc13267351609b557051230f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f21114dd6fbea5382b4a96c88ac344b |
| publicationDate |
2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7288655-B2 |
| titleOfInvention |
α v integrin receptor antagonists |
| abstract |
The present invention relates to the synthesis of intermediates for the preparation of compounds of formula (A): wherein n is 2 or 3 and various salt forms of these compounds. The compounds of formula (A) are useful as ανβ3 receptor antagonists |
| priorityDate |
2003-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |